Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor

التفاصيل البيبلوغرافية
العنوان: Rosuvastatin Enhances VSV-G Lentiviral Transduction of NK Cells via Upregulation of the Low-Density Lipoprotein Receptor
المؤلفون: Ying Gong, Gerard M. J. Bos, Ian Janssen, Roel G. J. Klein Wolterink, Arjan J. Groot, Wilfred T. V. Germeraad
المساهمون: Interne Geneeskunde, RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Radiotherapie, RS: GROW - R2 - Basic and Translational Cancer Biology, MUMC+: MA Hematologie (9)
المصدر: Molecular Therapy. Methods & Clinical Development
Molecular Therapy-Methods and Clinical Development, 17, 634-646. Nature Publishing Group
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 634-646 (2020)
بيانات النشر: American Society of Gene & Cell Therapy, 2020.
سنة النشر: 2020
مصطلحات موضوعية: 0301 basic medicine, lcsh:QH426-470, Cytotoxicity, Natural-killer-cells, Efficient gene-transfer, LDL RECEPTOR, Article, statins, Cell therapy, 03 medical and health sciences, Transduction (genetics), 0302 clinical medicine, Downregulation and upregulation, INFECTION, Genetics, Cytotoxic T cell, GGPP, lcsh:QH573-671, VSV-G, Receptor, Molecular Biology, natural killer cells, biology, Chemistry, lcsh:Cytology, T-cells, LIPOPHILIC STATINS, Vector transduction, lentiviral transduction, nutritional and metabolic diseases, biology.organism_classification, CHIMERIC ANTIGEN RECEPTOR, 3. Good health, lcsh:Genetics, 030104 developmental biology, LDLR, HEMATOPOIETIC STEM, Vesicular stomatitis virus, 030220 oncology & carcinogenesis, LDL receptor, Cancer research, Molecular Medicine, lipids (amino acids, peptides, and proteins), rosuvastatin
الوصف: Adoptive natural killer (NK) cell therapy is attaining promising clinical outcomes in recent years, but improvements are needed. Genetic modification of NK cells with a tumor antigen-specific receptor on their surface coupled to intracellular signaling domains may lead to enhanced cytotoxicity against malignant cells. One of the most common approaches is by lentivirus-mediated transduction. However, NK cells are difficult to transduce and various methods have been attempted with different success rates. Because the low-density lipoprotein-receptor (LDLR) is the receptor of vesicular stomatitis virus (VSV) and is expressed only at low levels on NK cells, we tested the potential of 5 statins and 5 non-statin compounds to increase the LDLR expression, thereby facilitating viral transduction. We found that the transduction efficiency of VSV-G pseudotyped lentivirus is augmented by statins that induced higher LDLR expression. In both NK-92 cells and primary NK cells, the transduction efficiency increased after treatment with statins. Furthermore, statins have been reported to suppress NK cell cytotoxicity; however, we showed that this can be completely reversed by adding geranylgeranyl-pyrophosphate (GGPP). Among the statins tested, we found that the combination of rosuvastatin with GGPP most potently improved viral transduction without affecting the cytotoxic properties of the NK cells.
Graphical Abstract
Natural killer (NK) cells are known to be difficult to transduce, and various methods have been attempted with different success rates. Gong and colleagues found that the combination of rosuvastatin with GGPP most potently improved VSV-G lentivirus transduction via upregulating cell surface LDLR without affecting the cytotoxic properties of the NK cells.
اللغة: English
تدمد: 2329-0501
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::724894981c6afdce3e5ff4894ff0e3f7
http://europepmc.org/articles/PMC7150439
Rights: OPEN
رقم الانضمام: edsair.doi.dedup.....724894981c6afdce3e5ff4894ff0e3f7
قاعدة البيانات: OpenAIRE